Quercetin treatment of SMMC-7721 and HepG2 HCC cells have shown decreased p-Akt, p-mTOR, p-p70S6K and p-4EBP1 protein levels thereby targeting Akt/mTOR inhibition and MAPK activation [48]. Here, AKT1 is linked to hepatocellular carcinoma.